Short Bowel Syndrome
128
14
18
75
Key Insights
Highlights
Success Rate
87% trial completion (above average)
Published Results
34 trials with published results (27%)
Research Maturity
75 completed trials (59% of total)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 17/100
8.6%
11 terminated out of 128 trials
87.2%
+0.7% vs benchmark
30%
39 trials in Phase 3/4
45%
34 of 75 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 75 completed trials
Clinical Trials (128)
A Study of Teduglutide in Japanese People With Short Bowel Syndrome
A 90 Day, Phase 3,Open Labeled Exploratory Study of RELiZORB
Resting Energy Expenditure by Gastrointestinal Functional Status
A Clinical Study of FT1 in Patients With Short Bowel Syndrome
A 90 Day Observational Study as an Extension to the Phase 3,Open Labeled Exploratory Study of RELiZORB
A Study of Teduglutide in Chinese Adults With Short Bowel Syndrome
Safety and Efficacy of Crofelemer in Adult Patients With Short Bowel Syndrome and Intestinal Failure (SBS-IF) Without Colon-in-continuity (CIC)
Evaluation of the Efficacy and Safety of Recombinant Human Growth Hormone (rhGH) in the Treatment of Children With Short Bowel Syndrome
Phase 2 Study to Assess the Safety, PK, and PD of Sonefpeglutide (HM15912) in SBS-IF Subjects
Efficacy And Safety Evaluation of Glepaglutide in Treatment of SBS
Efficacy and Safety of PJ009 in Patients With Short Bowel Syndrome Requiring Parenteral Nutrition
SBS DISK- Creation of a Quality of Life Tool for Short Bowel Patients Compared With a Validated Quality of Life Questionnaire (SBS QoL)
Open-Label Pilot Study With Crofelemer in Patients With Short Bowel Syndrome
Evaluation of Long Term Safety and Efficacy of Glepaglutide in Treatment of SBS - Extension Trial
Evaluation of Long Term Safety and Efficacy of Glepaglutide in Treatment of SBS
Palliative Care Needs of Children With Rare Diseases and Their Families
Gastrointestinal Hormone Secretion, Intestinal Permeability and Short Bowel Syndrome
Registry for Participants With Short Bowel Syndrome
A Feasibility Study to Evaluate Safety and Probable Benefit of the Eclipse XL1 System for Distraction Enterogenesis in Adult and Pediatric Patients With Short Bowel Syndrome
Effect of Parenteral Support on FibroScan in Short Bowel Syndrome